Many diabetes cases may go undetected by afternoon tests

December 25, 2000

Study suggests need for repeat testing for some patients

CHICAGO -- If current diagnostic criteria for diabetes are applied to patients tested in the afternoon, about half of cases of undiagnosed diabetes may be missed, according to an article in the December 27 issue of The Journal of the American Medical Association.

Rebecca J. Troisi, Sc.D., formerly of Social and Scientific Systems Inc., Bethesda, Md. (she is now with the National Cancer Institute), and Maureen I. Harris, Ph.D., M.P.H., and Catherine C. Cowie, Ph.D., from the National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md., evaluated the variation in fasting plasma glucose levels in samples taken at different times of the day to examine whether diagnostic criteria based on morning measurements can be applied to patients who are tested for diabetes in the afternoon. They analyzed data from the U.S. population-based Third National Health and Nutrition Examination Survey (NHANES III), conducted between 1988 and 1994. Study participants aged 20 or older who had no previously diagnosed diabetes were randomly assigned to morning or afternoon examinations.

Current diagnostic criteria for diabetes are based on plasma glucose levels in blood samples obtained in the morning after an overnight fast, with a value of 7.0 mmol/L (126 mg/dL) or more indicating diabetes. But according to background information cited in the study, many patients are seen by their physicians in the afternoon in an uncertain state of fasting. Plasma glucose has also been observed to be higher in the morning.

For the current study, a total of 6,483 people tested in the morning were asked not to eat or drink anything other than water after 8:30 p.m. on the day preceding the examination. The median fasting time for those tested in the morning was 13.5 hours. The other 6,399 participants were tested in either early or late afternoon. Those tested in early afternoon were asked to eat breakfast but not to eat or drink anything other than water after 7:30 a.m. on the day of the test. Those examined in late afternoon were asked to eat lunch, but not to eat or drink anything other than water after 11:30 a.m. The median fasting time for those examined in the afternoon was 7.0 hours. Study participants in the morning and afternoon groups were similar in age, sex, race, parental history of diabetes, body mass index, waist-to-hip ratio, physical activity, smoking status, alcohol intake, education, use of medications that may affect glucose levels, and glycosylated hemoglobin levels.

"Fasting plasma glucose increased with age, but morning subjects had higher glucose values at every age compared with afternoon subjects, with an overall mean difference of 0.28 mmol/L (5.0 mg/dL)," the authors write.

"Consequently, prevalence in afternoon subjects of glucose values indicating diabetes (1.4 percent) was one half that of morning subjects (2.8 percent)," they continue, and suggest that the differences in fasting plasma glucose levels between subjects examined in the morning and afternoon were clinically significant.

"We estimate that glucose values indicating diabetes for patients tested in the afternoon should be fully 0.67 mmol/L (12 mg/dL) lower than the current diagnostic criterion of 7.0 mmol/L (126 mg/dL) or greater," they write. "If the current criterion were applied to afternoon patients, about half the cases of undiagnosed diabetes would be missed in this group."

"Regardless of the time of day that patients are tested, physicians need to confirm the diagnosis by repeat testing on a different day," the authors suggest. "For those initially tested in the afternoon, a confirmatory morning test may be advised."
-end-
(JAMA. 2000; 284:3157-3159)

This release is reproduced verbatim and with permission from the American Medical Association as a service to reporters interested in health and behavioral change. For more information about The Journal of the American Medical Association or to obtain a copy of the study, please contact the American Medical Association's Science News Department at (312) 464-5374.

Posted by the Center for the Advancement of Health . For more research news and information, go to our special section devoted to health and behavior in the "Peer-Reviewed Journals" area of Eurekalert!, http://www.eurekalert.org/restricted/reporters/journals/cfah/. For information about the Center, call Petrina Chong, pchong@cfah.org (202) 387-2829.

Center for Advancing Health

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.